Population
Patients receiving intravenous aminophylline for conditions such as bronchial asthma, cardiac asthma…
Design
Review
Authors
Loading...
Reinforces caution with IV aminophylline use; leaves open its risk-benefit profile versus modern alternatives.
Intravenous administration of aminophylline, while effective for bronchospasm and certain cardiac conditions, may be associated with fatal toxic reactions.
Elliott Bresnick (1948) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: